Literature DB >> 2265479

In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

F P Guengerich1, D H Kim.   

Abstract

Recent in vivo studies in humans have shown a dramatic effect of grapefruit juice in blocking the oxidation of dihydropyridine calcium channel blockers. The flavonoid naringin is the most abundant natural product specific for grapefruit and related citrus--the aglycone naringenin, known to be readily formed from naringin in humans, was found to inhibit the oxidation of the dihydropyridines nifedipine and felodipine in human liver microsomal preparations. These observations were of interest in light of the knowledge that the same human liver cytochrome P450 (IIIA4) appears to be a major catalyst in both nifedipine oxidation and aflatoxin B1 activation. Several flavones inhibited the in vitro activation of aflatoxin B1 in a system employing umuC gene activation due to DNA damage in Salmonella typhimurium TA1535/pSK1002, with naringenin being as effective as any. The high concentration of derivatives of naringenin in certain citrus fruits may be of relevance to cancer chemoprevention involving those carcinogens that are activated by cytochrome P-450IIIA4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265479     DOI: 10.1093/carcin/11.12.2275

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

1.  Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.

Authors:  Wenjie Jessie Lu; Valentina Ferlito; Cong Xu; David Alastair Flockhart; Salvatore Caccamese
Journal:  Chirality       Date:  2011-09-22       Impact factor: 2.437

2.  In vitro modulatory effects of flavonoids on human cytochrome P450 2C8 (CYP2C8).

Authors:  Chia Yong Pang; Joon Wah Mak; Rusli Ismail; Chin Eng Ong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-04       Impact factor: 3.000

3.  Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance.

Authors:  B Edgar; D Bailey; R Bergstrand; G Johnsson; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.

Authors:  Yoko Honda; Fumihiko Ushigome; Noriko Koyabu; Satoshi Morimoto; Yukihiro Shoyama; Takeshi Uchiumi; Michihiko Kuwano; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

5.  Effect of grapefruit juice on cyclosporine pharmacokinetics.

Authors:  A Majeed; A Kareem
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

6.  In vitro techniques for studying drug metabolism.

Authors:  F P Guengerich
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

7.  Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers.

Authors:  U Merkel; H Sigusch; A Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

Authors:  U Fuhr; K Klittich; A H Staib
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

10.  In vitro inhibition of midazolam and quinidine metabolism by flavonoids.

Authors:  H R Ha; J Chen; P M Leuenberger; A U Freiburghaus; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.